| Field | Specification |
|---|---|
| Mfr No | |
| Species |
MDA-MB-231-GFP is a fluorescently labeled variant of the widely used MDA-MB-231 human breast cancer cell line, engineered to express green fluorescent protein (GFP) via lentiviral transduction. This modification enables real-time visualization and quantification of tumor cell dynamics both in vitro and in vivo, facilitating detailed analysis of tumor-stroma interactions, cellular proliferation, and metastatic behavior. The parental MDA-MB-231 line originates from a pleural effusion of a patient with triple-negative breast cancer (TNBC) and exhibits aggressive, invasive behavior with a mesenchymal phenotype, making it a cornerstone model for studying TNBC pathophysiology and treatment resistance.
In co-culture experiments with human mesenchymal stem/stromal cells (MSCs), MDA-MB-231-GFP cells have demonstrated significantly enhanced proliferation and tumor-promoting behavior. Studies showed that direct contact with MSCs, rather than soluble factors alone, is critical for this effect. Specifically, co-culture with MSCs led to a 39.5% increase in MDA-MB-231-GFP cell proliferation after four days compared to monoculture, and induced expression of CD90 on a subset of breast cancer cells—a marker not expressed under standard conditions. This MSC-induced CD90 expression required direct cell–cell interaction and was partially inhibited by blocking gap junctions or Notch signaling, indicating the involvement of specific intercellular communication pathways.
In vivo, co-injection of MDA-MB-231-GFP cells with MSCs into immunodeficient NOD/scid mice resulted in approximately tenfold increased tumor volume and enhanced metastatic potential compared to injection of cancer cells alone. These tumors exhibited elevated vascularization and higher viability, and retained a minority CD90-positive population, reinforcing the in vitro findings. Together, these studies position MDA-MB-231-GFP as a robust model for investigating tumor-stroma interactions, MSC-induced phenotypic plasticity, and mechanisms of tumor progression in triple-negative breast cancer.
—
- Protein expression: GFP
- Mutational profile: Mutation: p.Gly464Val, Heterozygous; Mutation: p.Gly13Asp, Heterozygous; Mutation: p.Arg280Lys, Homozygous
- cultureMedium: DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 1.6 mM L-Glutamine, w: 15 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion 820400a)
- supplements: Supplement the medium with 5% FBS
- dissociationReagent: Accutase
- freezeMedium: As a cryopreservation medium, use complete growth medium + 10% DMSO for adequate post-thaw viability.
10%
OFF
15%OFF
20%
OFF
$50
OFF
FREE
SAMPLE
